Following a 731 percent increase in utilization of the drug (up to more than 23,000 members utilizing GLP-1s for weight loss purposes) by 2024, the Board estimated the cost in 2024 to exceed $170 million and jump to more than $1 billion over the next six years
Clinical Knowledge Summary
Anti-inflammatory effects of GLP-1-based therapies beyond glucose control
These include lean mass loss, micronutrient insufficiencies and digestive discomfort, all of which can undermine therapeutic outcomes and long-term metabolic health
doi: 10.1080/19490976.2025.2528428 41 ChouY
Yes, you should always inform healthcare providers about Ozempic use, particularly before surgery or procedures, as semaglutide slows gastric emptying and may interact with certain medications such as warfarin or levothyroxine